Where Did the Authors Work When They Conducted Their Clinical Pharmacology Studies?
NCT07115680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 503
Last updated 2026-07-31
Summary
It is unknown in which countries the clinical pharmacology studies published in leading specialized journals were conducted. The hypothesis is that studies in this specialty tend to be conducted and published by authors from a single country. This analysis aims to describe the number of collaborators and the countries in which they worked, using the Nature Index concept of "share."
Conditions
- Scientific Collaboration in Clinical Pharmacology
Interventions
- OTHER
-
human participants, data or material
Articles on human participants, data, or material published in top (as per JCR IF) clinical pharmacology journals linked to professional societies
Sponsors & Collaborators
-
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
lead OTHER
Principal Investigators
-
Rafael Dal-Re, MD, PhD, MPH · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-15
- Primary Completion
- 2025-11-04
- Completion
- 2025-11-30
Countries
- Spain
Study Locations
More Related Trials
-
STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study
NCT01181505 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study to Characterize Individual Metabolic Profile
NCT01188525 ·Status: COMPLETED ·Phase: PHASE1
-
Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury
NCT06547229 ·Status: ACTIVE_NOT_RECRUITING
-
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
NCT00414115 ·Status: RECRUITING
-
Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780
NCT06576765 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetic Profile of an Infusion of Cilastatin in Healthy Volunteers.
NCT03595189 ·Status: COMPLETED ·Phase: PHASE1
-
Population Pharmacokinetic - Pharmacodynamic Models of Chronic Disease Therapeutics for Smokers
NCT05126381 ·Status: UNKNOWN
-
Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers
NCT03866928 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone
NCT06388616 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
NCT07076030 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects
NCT06126562 ·Status: COMPLETED ·Phase: PHASE1
-
Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)
NCT02061826 ·Status: UNKNOWN
-
A Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901
NCT02975388 ·Status: COMPLETED ·Phase: PHASE1
-
A Prognostic Model for Drug-induced Liver Injury in China
NCT05060289 ·Status: RECRUITING
-
Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function
NCT05735951 ·Status: COMPLETED ·Phase: PHASE1
-
A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males
NCT04183517 ·Status: COMPLETED ·Phase: PHASE1
-
Reduction of Adverse Drug Events and Readmissions
NCT02738047 ·Status: RECRUITING
-
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)
NCT00413634 ·Status: COMPLETED ·Phase: PHASE2
-
A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT
NCT04193436 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
NCT06357910 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.
NCT02623868 ·Status: COMPLETED ·Phase: PHASE1
-
A Retrospective Study on Drug Induced Liver Injury in China
NCT02407964 ·Status: COMPLETED
-
Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers
NCT04734275 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function
NCT06657560 ·Status: COMPLETED ·Phase: PHASE1
-
PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects
NCT03942666 ·Status: COMPLETED ·Phase: PHASE1